Model for the peptide-free conformation of class II MHC proteins

PLoS ONE

Volumn 3, Issue 6, 2008, Pages

  Painter, Corrie A ^a   Cruz, Anthony ^b   López, Gustavo E ^b   Stern, Lawrence J ^a   Zavala Ruiz, Zarixia ^c  

^a UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF PUERTO RICO   (Puerto Rico)

^c UNIVERSITY OF PUERTO RICO   (Puerto Rico)

Author keywords

[No Author keywords available]

Indexed keywords

HLA DM ANTIGEN; HLA DR1 ANTIGEN; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; PHENYLALANINE; MONOCLONAL ANTIBODY; PEPTIDE;

ALPHA CHAIN; ARTICLE; BINDING SITE; COMPUTER SIMULATION; CONTROLLED STUDY; CRYSTAL STRUCTURE; HYDROGEN BOND; MOLECULAR DYNAMICS; MOLECULAR MODEL; NONHUMAN; PREDICTION; PROTEIN BINDING; PROTEIN CONFORMATION; PROTEIN FOLDING; PROTEIN PROTEIN INTERACTION; PROTEIN SECRETION; AMINO ACID SEQUENCE; CHEMICAL STRUCTURE; CHEMISTRY; IMMUNOLOGY; MOLECULAR PROBE;

AMINO ACID SEQUENCE; ANTIBODIES, MONOCLONAL; HLA-DR1 ANTIGEN; MODELS, MOLECULAR; MOLECULAR PROBES; PEPTIDES; PROTEIN CONFORMATION;

EID: 48749111890     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0002403     Document Type: Article

References (59)

1. Trombetta ES, Mellman I (2005) Cell biology of antigen processing in vitro and in vivo. Annu Rev Immunol 23: 975-1028.
2. McFarland BJ, Beeson C (2002) Binding interactions between peptides and proteins of the class II major histocompatibility complex. Med Res Rev 22: 168-203.
3. Stern LJ, Brown JH, Jardetzky TS, Gorga JC, Urban RG, et al. (1994) Crystal structure of the human class II MHC protein HLA-DR1 complexed with an influenza virus peptide. Nature 368: 215-221.
4. Lovitch SB, Unanue ER (2005) Conformational isomers of a peptide-class II major histocompatibility complex. Immunol Rev 207: 293-313.
5. Kasson PM, Rabinowitz JD, Schmitt L, Davis MM, McConnell HM (2000) Kinetics of peptide binding to the class II MHC protein I-Ek. Biochemistry 39: 1048-1058.
6. Belmares MP, Busch R, Meflins ED, McConnell HM (2003) Formation or two peptide/MHC II isomers is catalyzed differentially by HLA-DM. Biochemistry 42: 838-847.
7. Schmitt L, Boniface JJ, Davis MM, McConnell HM (1999) Conformational isomers of a class II MHC-peptide complex in solution. J Mol Biol 286: 207-218.
8. Hansen TH, Lybarger L, Yu L, Mitaksov V, Fremont DH (2005) Recognition of open conformers of classical MHC by chaperones and monoclonal antibodies. Immunol Rev 207: 100-111.
9. Zarutskie JA, Sato AK, Rushe MM, Chan IC, Lomakin A, et al. (1999) A conformational change in the human major histocompatibility complex protein HLA-DR1 induced by peptide binding. Biochemistry 38: 5878-5887.
10. Sato AK, Zarutskie JA, Rushe MM, Lomakin A, Natarajan SK, et al. (2000) Determinants of the peptide-induced conformational change in the human class II major histocompatibility complex protein HLA-DR1. J Biol Chem 275: 2165-2173.
11. Rabinowitz JD, Vrljic M, Kasson PM, Liang MN, Busch R, et al. (1998) Formation of a highly peptide-receptive state of class II MHC. Immunity 9: 699-709.
12. Natarajan SK, Stern LJ, Sadegh-Nasseri S (1999) Sodium dodecyl sulfate stability of HLA-DR1 complexes correlates with burial of hydrophobic residues in pocket 1. J Immunol 162: 3463-3470.
13. Joshi RV, Zarutskie JA, Stern LJ (2000) A three-step kinetic mechanism for peptide binding to MHC class II proteins. Biochemistry 39: 3751-3762.
14. Zarutskie JA, Busch R, Zavala-Ruiz Z, Rushe M, Melfins ED, et al. (2001) The kinetic basis of peptide exchange catalysis by HLA-DM. Proc Natl Acad Sci U S A 98: 12450-12455.
15. Grotenbreg GM, Nicholson MJ, Fowler KD, Wilbuer K, Octavio L, et al. (2007) Empty class II MHC created by peptide photolysis establishes role of DM in peptide association. J Biol Chem.
16. Carven GJ, Chitta S, Hilgert I, Rushe MM, Baggio RF, et al. (2004) Monoclonal antibodies specific for the empty conformation of HLA-DR1 reveal aspects of the conformational change associated with peptide binding. J Biol Chem 279: 16561-16570.
17. Carven GJ, Stern LJ (2005) Probing the ligand-induced conformational change in HLA-DR1 by selective chemical modification and mass spectrometric mapping. Biochemistry 44: 13625-13637.
18. Zheng W, Brooks BR, Thirumalai D (2007) Allosteric transitions in the chaperonin GroEL are captured by a dominant normal mode that is most robust to sequence variations. Biophys J 93: 2289-2299.
19. Laberge M, Yonetani T (2008) Molecular dynamics simulations of hemoglobin A in different states and bound to DPG: effector-linked perturbation of tertiary conformations and HbA concerted dynamics. Biophys J 94: 2737-2751.
20. Frayser M, Sato AK, Xu L, Stern LJ (1999) Empty and peptide-loaded class II major histocompatibility complex proteins produced by expression in Escherichia coli and folding in vitro. Protein Expr Purif 15: 105-114.
21. Cochran JR, Stern LJ (2000) A diverse set of oligomeric class II MHC-peptide complexes for probing T-cell receptor interactions. Chem Biol 7: 683-696.
22. Stern LJ, Wiley DC (1992) The human class II MHC protein HLA-DR1 assembles as empty alpha beta heterodimers in the absence of antigenic peptide. Cell 68: 465-477.
23. Zavala-Ruiz Z, Strug I, Walker BD, Norris PJ, Stern LJ (2004) A hairpin turn in a class II MHC-bound peptide orients residues outside the binding groove for T cell recognition. Proc Natl Acad Sci U S A 101: 13279-13284.
24. Kony DB, Hunenberger PH, van Gunsteren WF (2007) Molecular dynamics simulations of the native and partially folded states of ubiquitin: Influence of methanol cosolvent, pH, and temperature on the protein structure and dynamics. Protein Sci 16: 1101-1118.
25. Berendsen HJC, Postma JPM, van Gunsteren WF, DiNola A, Haak JR (1984) Molecular dynamics with coupling to an external bath. J Chem Phys 81: 3684-3690.
26. Essmann U, Perera L, Berkowitz ML, Darden T, Lee H, et al. (1995) A smooth particle mesh Ewald potential. J Chem Phys 103: 8577-8592.
27. Hess B, Bekker H, Berendsen HJC, FJ (1997) GEM, LINCS: A linear constraint solver for molecular simulations. J Comp Chem 18: 1463-1472.
28. Villa E, Balaeff A, Schulten K (2005) Structural dynamics of the late repressor-DNA complex revealed by a multiscale simulation. Proc Natl Acad Sci U S A 102: 6783-6788.
29. Berendsen HJC, van der Spoel D, van Drunen R (1995) GROMACS:A messeage-passing parallel molecular dynamic implementation. Comp Phys Comm 91: 43-56.
30. Humphrey W, Dalke A, Schulten K (1996) VMD: visual molecular dynamics. J Mol Graph 14: 33-38, 27-38.
31. Zavala-Ruiz Z, Strug I, Anderson MW, Gorski J, Stern LJ (2004) A polymorphic pocket at the P10 position contributes to peptide binding specificity in class II MHC proteins. Chem Biol 11: 1395-1402.
32. Schneider TR (2000) Objective comparison of protein structures: error-scaled difference distance matrices. Acta Cryst D56: 714-721.
33. Nojima H, Takeda-Shitaka M, Kurihara Y, Kamiya K, Umeyama H (2003) Dynamic flexibility of a peptide-binding groove of human HLA-DR1 class II MHC molecules: normal mode analysis of the antigen peptide-class II MHC complex. Chem Pharm Bull (Tokyo) 51: 923-928.
34. Gupta S, Hopner S, Rupp B, Gunther S, Dickhaut K, et al. (2008) Anchor side chains of short peptide fragments trigger ligand-exchange of class II MHC molecules. PLoS ONE 3: e1814.
35. Sundberg EJ, Deng L, Mariuzza RA (2007) TCR recognition of peptide/MHC class II complexes and superantigens. Semin Immunol 19: 262-271.
36. Sundberg EJ, Andersen PS, Schlievert PM, Karjalainen K, Mariuzza RA (2003) Structural, energetic, and functional analysis of a protein-protein interface at distinct stages of affinity maturation. Structure 11: 1151-1161.
37. Andersen PS, Lavoie PM, Sekaly RP, Churchill H, Kranz DM, et al. (1999) Role of the T cell receptor alpha chain in stabilizing TCR-superantigen-MHC class II complexes. Immunity 10: 473-483.
38. Fu XT, Karr RW (1991) HLA-DR alpha chain residues located on the outer loops are involved in nonpolymorphic and polymorphic antibody-binding epitopes. Hum Immunol 39: 253-260.
39. Chou CL, Sadegh-Nasseri S (2000) HLA-DM recognizes the flexible conformation of major histocompatibility complex class II. J Exp Med 192: 1697-1706.
40. Natarajan SK, Assadi M, Sadegh-Nasseri S (1999) Stable peptide binding to MHC class II molecule is rapid and is determined by a receptive conformation shaped by prior association with low affinity peptides. J Immunol 162: 4030-4036.
41. Reich Z, Altman JD, Boniface JJ, Lyons DS, Kozono H, et al. (1997) Stability of empty and peptide-loaded class II major histocompatibility complex molecules at neutral and endosomal PH: comparison to class I proteins. Proc Natl Acad Sci U S A 94: 2495-2500.
42. Runnels HA, Moore JC, Jensen PE (1996) A structural transition in class II major histocompatibility complex proteins at mildly acidic pH. J Exp Med 183: 127-136.
43. Boniface JJ, Lyons DS, Wettstein DA, Allbritton NL, Davis MM (1996) Evidence for a conformational change in a class II major histocompatibility complex molecule occurring in the same pH range where antigen binding is enhanced. J Exp Med 183: 119-126.
44. Sadegh-Nasseri S, Stern LJ, Wiley DC, Germain RN (1994) MHC class II function preserved by low-affinity peptide interactions preceding stable binding. Nature 370: 647-650.
45. O'Sullivan D, Sidney J, Appella E, Walker L, Phillips L, et al. (1990) Characterization of the specificity of peptide binding to four DR haplotypes. J Immunol 145: 1799-1808.
46. Hammer J, Takacs B, Sinigaglia F (1992) Identification of a motif for HLA-DR1 binding peptides using M13 display libraries. J Exp Med 176: 1007-1013.
47. Denzin LK, Hammond C, Cresswell P (1996) HLA-DM interactions with intermediates in HLA-DR maturation and a role for HLA-DM in stabilizing empty HLA-DR molecules. J Exp Med 184: 2153-2165.
48. Kropshofer H, Arndt SO, Moldenhauer G, Hammerling GJ, Vogt AB (1997) HLA-DM acts as a molecular chaperone and rescues empty HLA-DR molecules at lysosomal pH. Immunity 6: 293-302.
49. Doebele RC, Busch R, Scott HM, Pashine A, Mellins ED (2000) Determination of the HLA-DM interaction site on HLA-DR molecules. Immunity 13: 517-527.
50. Narayan K, Chou CL, Kim A, Hartman IZ, Dalai S, et al. (2007) HLA-DM targets the hydrogen bond between the histidine at position beta81 and peptide to dissociate HLA-DR-peptide complexes. Nat Immunol 8: 92-100.
51. Brown JH, Jardetzky TS, Gorga JC, Stern LJ, Urban RG, et al. (1993) Three-dimensional structure of the human class II histocompatibility antigen HLA-DRI. Nature 364: 33-39.
52. Bouvier M, Wiley DC (1998) Structural characterization of a soluble and partially folded class I major histocompatibility heavy chain/beta 2m heterodimer. Nat Struct Biol 5: 377-384.
53. Fahnestock ML, Tamir I, Narhi L, Bjorkman PJ (1992) Thermal stability comparison of purified empty and peptide-filled forms of a class I MHC molecule. Science 258: 1658-1662.
54. Glithero A, Tormo J, Doering K, Kojima M, Jones EY, et al. (2006) The crystal structure of H-2D)(b) complexed with a partial peptide epitope suggests a major histocampatibility complex class I assembly intermediate. J Biol Chem 281: 12699-12704.
55. Zacharias M, Springer S (2004) Conformational flexibility of the MHC class I alpha1-alpha2 domain in peptide bound and free states: a molecular dynamics simulation study. Biophys J 87: 2203-2214.
56. Sieker F, Springer S, Zacharias M (2007) Comparative molecular dynamics analysis of tapasin-dependent and -independent MHC class I alleles. Protein Sci 16: 299-308.
57. Bolin DR, Swain AL, Sarabu R, Berthel SJ, Gillespie P, et al. (2000) Peptide and peptide mimetic inhibitors of antigen presentation by HLA-DR class II MHC molecules. Design, structure-activity relationships, and X-ray crystal structures. J Med Chem 13: 2135-2148.
58. DeLano WL (2002) The PyMol molecular graphics system. San Carlos, CA: DeLano Scientific.
59. Kleywegt GJ (1999) Experimental assessment or differences between related protein crystal structures. Acta Crystallogr D Biol Crystallogr 55: 1878-1884.